Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 210479/Z/18/Z
NICHD NIH HHS
Grant: K08 HD094638
NIAID NIH HHS
Grant: T32 AI007433
Wellcome Trust
Fields of Study
Keywords
Sustainable Development Goals